Emma C. E. Wassenaar

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 312 citations · Full text

Health Sciences, Gastrointestinal Oncology, Medicine +8

Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases

Johannes G. Reiter, Wei‐Ting Hung, I‐Hsiu Lee et al. · Nature Genetics · 2020 · 119 citations · Full text

Tumor Biology, Lymphoid Neoplasia, Tumor Heterogeneity +13

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Koen P. Rovers, Checca Bakkers, Geert A. Simkens et al. · BMC Cancer · 2019 · 108 citations · Full text

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

Inge Ubink, Ana C.F. Bolhaqueiro, Sjoerd G. Elias et al. · British journal of surgery · 2019 · 105 citations · Full text

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity

Jamila Laoukili, Alexander Constantinides, Emma C. E. Wassenaar et al. · British Journal of Cancer · 2022 · 61 citations · Full text